coadministered cagrilintide and semaglutide in adults with overweight or obesity 2.4 mg Cagrilintide and Semaglutide CagriSema achieves >20% weight loss
Description
Your Hair Isn't Falling Out
SCFA may stimulate the release of GLP-1 by binding to the L-cell receptors
Stimulates insulin secretion when blood glucose rises, suppresses glucagon, slows gastric emptying
Semaglutide's most common side effectsnausea, constipation, and mild appetite reductionare gastrointestinal and typically decrease over weeks as your body adjusts
